Found 7 matching trials
LME-Guided Precision Combination Therapy in B-cell Lymphoma Patients After CD19 CAR-T Failure PHASE2 This study evaluates a personalized treatment strategy for patients with la...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
Learn More & Join Trial
Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma PHASE2 The goal of this clinical trial is to see if a new combination of standard ...
Show More Location
Townsville University Hospital
Learn More & Join Trial
Gazyvaro and Low Dose Radiotherapy in Early Stage Follicular Lymphoma PHASE2 Combined modality approach using Obitunuzumab and involved site low dose ir...
Show More Location
University of Tuebingen
Learn More & Join Trial
Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi PHASE3 Prospective, multicenter, open label, phase III randomized clinical trial i...
Show More Location
Nuovo Ospedale Civile di Sassuolo - Day Hospital Oncologico
Learn More & Join Trial
Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy PHASE2 This single-arm phase II interventional study aims to assess disease respon...
Show More Status
Active Not Recruiting
Location
Ballarat Health Service
Learn More & Join Trial
Hypofractionation Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse B-cell Lymphoma With Baseline High Tumor Burden PHASE2 Glofitamab has shown efficacy and safety in the treatment of patients with ...
Show More Location
Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
Learn More & Join Trial
Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody PHASE3 The MIR study proved the effect of Rituximab in combination with a localize...
Show More Location
Vivantes Klinikum Berlin
Learn More & Join Trial